104 related articles for article (PubMed ID: 18479305)
1. Evaluation of morpho/immunological telehaematology file exchanges for the inclusion of patients with chronic lymphocytic leukaemia in a therapeutic trial.
Lesesve J; Palmiéri A; Brion A; Feugier P; Mahé B; Garand R;
Int J Lab Hematol; 2008 Jun; 30(3):256-8. PubMed ID: 18479305
[No Abstract] [Full Text] [Related]
2. [Phenotypic changes in peripheral blood lymphocytes of patients with chronic lymphoma and B-cell leukemia after treatment].
Rupniewska ZM; Rozynkowa D; Kowal M; Antosz H; Roliński J; Wach M
Acta Haematol Pol; 1990; 21(2):192-206. PubMed ID: 2131719
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of chronic lymphocytic leukemia in relation to clinico- morphological characteristics of the disease].
Tumakov VA; Abdulkadyrov KM; Rugal' VI; Karpenkov MV; Ved' VV; Brodovskiĭ AF
Klin Med (Mosk); 1991 Jan; 69(1):94-7. PubMed ID: 2023411
[TBL] [Abstract][Full Text] [Related]
4. Membranous glomerulonephritis in chronic lymphocytic leukemia.
Ziakas PD; Giannouli S; Psimenou E; Nakopoulou L; Voulgarelis M
Am J Hematol; 2004 Jul; 76(3):271-4. PubMed ID: 15224365
[TBL] [Abstract][Full Text] [Related]
5. The effect of subsequent therapies in patients with chronic lymphocytic leukemia previously treated with prednisone and either cladribine or chlorambucil.
Robak T; Blonski JZ; Kasznicki M; Góra-Tybor J; Dmoszyñska A; Skotñicki A
Haematologica; 2005 Jul; 90(7):994-6. PubMed ID: 15996945
[TBL] [Abstract][Full Text] [Related]
6. The chronic leukemias: current and novel therapeutic approaches.
Rathore R; Elfenbein GJ
Med Health R I; 2003 Aug; 86(8):240-2. PubMed ID: 14582218
[TBL] [Abstract][Full Text] [Related]
7. Paraneoplastic erythropoietin-induced polycythemia associated with small lymphocytic lymphoma.
Al-Tourah AJ; Tsang PW; Skinnider BF; Hoskins PJ
J Clin Oncol; 2006 May; 24(15):2388-9. PubMed ID: 16710039
[No Abstract] [Full Text] [Related]
8. Why R-CHOP for first line treatment of chronic lymphocytic leukemia?
Smolej L
Int J Lab Hematol; 2007 Dec; 29(6):478-9; author reply 479. PubMed ID: 17988306
[No Abstract] [Full Text] [Related]
9. Blood histamine levels in patients with chronic lymphocytic leukemia.
Belcheva A
Inflamm Res; 1999 Apr; 48 Suppl 1():S53-4. PubMed ID: 10350160
[No Abstract] [Full Text] [Related]
10. Adding fresh frozen plasma to rituximab for the treatment of patients with refractory advanced CLL.
Klepfish A; Rachmilewitz EA; Kotsianidis I; Patchenko P; Schattner A
QJM; 2008 Sep; 101(9):737-40. PubMed ID: 18650226
[TBL] [Abstract][Full Text] [Related]
11. [Multiple myeloma and chronic lymphocytic leukemia].
Labardini-Méndez J; Alexanian R; Barlogie B
Rev Invest Clin; 1997 May; 49 Suppl 1():28-33. PubMed ID: 9380986
[No Abstract] [Full Text] [Related]
12. Bendamustine in chronic lymphocytic leukemia and refractory lymphoma.
Rummel MJ
Semin Hematol; 2008 Jul; 45(3 Suppl 2):S7-10. PubMed ID: 18760709
[TBL] [Abstract][Full Text] [Related]
13. [Chronic lymphocytic leukemia in Subsaharian Africa: clinical outcome experience of Côte d'Ivoire].
Koffi KG; Nanho DC; Tolo A; N'Dathz E; Kouakou B; Meite N; Ayemou R; Sanogo I
Bull Cancer; 2009 Sep; 96(9):901-6. PubMed ID: 19696007
[TBL] [Abstract][Full Text] [Related]
14. Pseudohyperkalemia in chronic lymphocytic leukemia.
Ruddy KJ; Wu D; Brown JR
J Clin Oncol; 2008 Jun; 26(16):2781-2. PubMed ID: 18509189
[No Abstract] [Full Text] [Related]
15. Autoimmune pancytopenia following combination chemotherapy for chronic lymphocytic leukaemia.
MacCallum S; Groves M; Brass D; Cunningham J; Sales M; Gelly K; Tauro S
J Clin Pathol; 2009 May; 62(5):468-70. PubMed ID: 19398596
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and toxicity of 2 schedules of frontline rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone plus bortezomib in patients with B-cell lymphoma: a randomized phase 2 trial from the French Adult Lymphoma Study Group (GELA).
Ribrag V; Gisselbrecht C; Haioun C; Salles G; Golfier JB; Ertault M; Ferme C; Briere J; Brice P; Mounier N
Cancer; 2009 Oct; 115(19):4540-6. PubMed ID: 19593797
[TBL] [Abstract][Full Text] [Related]
17. [Chronic lymphocytic and prolymphocytic leukemia].
Gerrits CJ; Michiels JJ
Ned Tijdschr Geneeskd; 1995 Apr; 139(16):826-30. PubMed ID: 7731474
[No Abstract] [Full Text] [Related]
18. Durable remission of Sézary syndrome after unrelated bone marrow transplantation by reduced-intensity conditioning.
Kahata K; Hashino S; Takahata M; Fujisawa F; Kondo T; Kobayashi S; Fujita Y; Shimizu H; Imamura M; Asaka M
Acta Haematol; 2008; 120(1):14-8. PubMed ID: 18716396
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of a telemedicine system for the transmission of morpho/immunological data at the inclusion of patients in a therapeutic trial (Goelams LLC 98)].
Lesesve JF; Palmiéri A; Brion A; Feugier P; Mahé B; Garand R;
Ann Biol Clin (Paris); 2007; 65(2):143-52. PubMed ID: 17353168
[TBL] [Abstract][Full Text] [Related]
20. Activity of cladribine combined with cyclophosphamide in frontline therapy for chronic lymphocytic leukemia with 17p13.1/TP53 deletion: report from the Polish Adult Leukemia Group.
Robak T; Blonski JZ; Wawrzyniak E; Gora-Tybor J; Palacz A; Dmoszynska A; Konopka L; Warzocha K; Jamroziak K
Cancer; 2009 Jan; 115(1):94-100. PubMed ID: 19025975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
